# Cumberland Pharmaceuticals (CPIX) — Earnings

CPIX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cpix/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2022 |
| Period end | Sep 30, 2022 |
| EPS actual | −$0.03 |
| EPS estimate | $0.00 |
| EPS surprise | +0.00% |
| Revenue surprise | +0.00% |
| Revenue | $11.4M |
| Revenue estimate | $0.00 |
| Reported | Nov 8, 2022 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1087294/000162828022028987/cpix-20221108.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/c07930ee-2cbd-43ab-aa91-b7e8f55cfc41.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2022 | Nov 8, 2022 | $0.00 | −$0.03 | 0.00% | — | $11.4M |
| Q2 2022 | Aug 9, 2022 | $0.00 | −$0.09 | 0.00% | — | $10.3M |
| Q1 2022 | May 10, 2022 | $0.00 | −$0.09 | 0.00% | — | $11.2M |
| Q4 2021 | Mar 8, 2022 | −$0.01 | −$0.26 | -2500.00% | $12.2M | $8.3M |
| Q3 2021 | Nov 9, 2021 | −$0.11 | −$0.07 | 36.36% | $9.2M | $8.1M |
| Q2 2021 | Aug 10, 2021 | −$0.13 | $0.08 | 161.54% | $8.6M | $9.1M |
| Q1 2021 | May 11, 2021 | −$0.13 | $0.01 | 107.69% | $8.5M | $10.5M |
| Q4 2020 | Mar 9, 2021 | −$0.06 | −$0.06 | 0.00% | $9.8M | $10.3M |
| Q3 2020 | Nov 10, 2020 | −$0.18 | −$0.03 | 83.33% | $8.6M | $9.3M |
| Q2 2020 | Aug 11, 2020 | −$0.06 | −$0.06 | 0.00% | $9.3M | $9.6M |
| Q1 2020 | May 20, 2020 | −$0.13 | −$0.07 | 46.15% | $9.6M | $8.3M |

## Frequently Asked Questions

### When did Cumberland Pharmaceuticals (CPIX) last report earnings?

Cumberland Pharmaceuticals last reported on Nov 8, 2022, covering fiscal Q3 2022.

### Did CPIX beat earnings estimates?

Cumberland Pharmaceuticals reported EPS of −$0.03 for Q3 2022, in line with the $0.00 consensus estimate.

### How much revenue did CPIX report last quarter?

Cumberland Pharmaceuticals reported $11.4M in revenue for Q3 2022.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).